SEC Form 4 research
| Issuer | Xenon Pharmaceuticals Inc. |
|---|---|
| Tickers | XENE |
| Reporting owners | 39 |
| Officers and directors | 18 |
| Last public filing | 2026-10-01 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-01 | 2026-09-30 | Kelly Thomas Patrick | P | 15,000 | $37.32 | Not reported |
| 2026-10-01 | 2026-09-30 | MORTIMER IAN | P | 30,000 | $37.38 | Not reported |
| 2026-08-31 | 2026-08-28 | KENNEY CHRISTOPHER JOHN | S | 700 | $60.98 | Not reported |
| 2026-08-31 | 2026-08-28 | KENNEY CHRISTOPHER JOHN | S | 6,368 | $60.17 | Not reported |
| 2026-08-13 | 2026-08-11 | GANNON STEVEN | S | 10,000 | $64.06 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.